MCI’s Lemonade Stand series tackles ethics of male contraceptives, clinical trials, and more

The Male Contraceptive Initiative launched their “Lemonade Stand” discussion series as a way to bring the male contraception research community together in a virtual space during the COVID-19 pandemic, “making lemons into lemonade by connecting and sharing.”

So far, the webinar series has covered a variety of emerging questions from the field to drive the advancement of male contraception from clinical trials to market, including the regulatory process, manufacturing process, and multipurpose prevention technologies (MPTs). Stay tuned for ongoing conversations.

Missed a previous discussion? Check out the recordings:

• Chemistry, Manufacturing, & Controls (CMC) with Lex Smith, ADS Pharma Consulting, LLC

• Male Contraceptive's Regulatory & Clinical Trial Issues with Dr. Diana Blithe, NICHD & Dr. Lisa Rarick, RAR Consulting, LLC

• Multipurpose Prevention Technologies (MPTs) & Male Contraception with Dr. Bethany Young Holt, CAMI Health

• "Shared Risk” and the Ethics of Male Contraception with Dr. Georgina Campelia, Carmen Abbe, Evy McElmeel, and Dr. John Amory

• The Funding Landscape of Male Contraceptive Research & Development with Maya Goldstein, Policy Cures Research [Note the G-FINDER reports for 2020 (discussed in the conversation) and 2014 can also be found in the CTI Exchange Resource Library.]

Join the next conversation!

Join MCI for their next discussion, Reproductive Longevity and Building a Consortium on Thursday, January 21st at 2:00pm EST.

The conversation will revolve around reproductive longevity and how the diverse subsets of reproductive health can align. Bevin Lin and Jennifer Garrison from the Buck Institute will present their work in developing the Global Consortium for Reproductive Longevity & Equality, with a group discussion on how other reproductive health fields such as male contraception can join forces.

Register for the discussion here.